Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

The Lancet Infectious Diseases

Volumn 13, Issue 9, 2013, Pages 785-796

  Munoz Price, L Silvia ^a,b   Poirel, Laurent ^c   Bonomo, Robert A ^d,e   Schwaber, Mitchell J ^f   Daikos, George L ^g   Cormican, Martin ^h   Cornaglia, Giuseppe ⁱ   Garau, Javier ^j   Gniadkowski, Marek ^k   Hayden, Mary K ^l   Kumarasamy, Karthikeyan ^m   Livermore, David M ^n,o   Maya, Juan J ^p   Nordmann, Patrice ^m   Patel, Jean B ^q   Paterson, David L ^r   Pitout, Johann ^s,t   Villegas, Maria Virginia ^p   Wang, Hui ^u   Woodford, Neil ^o   Quinn, John P ^v   more..

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e Department of Microbiology ^*  (United States)

^f MINISTRY OF HEALTH   (Israel)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h NATIONAL UNIVERSITY OF IRELAND   (Ireland)

ⁱ UNIVERSITY OF VERONA   (Italy)

^j UNIVERSITY OF BARCELONA   (Spain)

^k NATIONAL MEDICINES INSTITUTE   (Poland)

^l RUSH UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF MADRAS   (India)

ⁿ UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^o PUBLIC HEALTH ENGLAND   (United Kingdom)

^p CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^q NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^r UNIVERSITY OF QUEENSLAND   (Australia)

^s CALGARY LABORATORY SERVICES   (Canada)

^t UNIVERSITY OF CALGARY   (Canada)

^u PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^v ASTRAZENECA   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AVIBACTAM; AZTREONAM; BIAPENEM; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; COLISTIN; ERAVACYCLINE; GENTAMICIN; IMIPENEM; MEROPENEM; PLAZOMICIN; QUINOLONE DERIVATIVE; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUSTRALIA AND NEW ZEALAND; BACTERIUM DETECTION; BACTERIUM ISOLATE; CANADA; CHINA; FRANCE; GREECE; HUMAN; INDIA; INFECTION CONTROL; INTENSIVE CARE UNIT; IRELAND; ISRAEL; ITALY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MORTALITY; POLAND; PORTUGAL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOUTH AND CENTRAL AMERICA; SPAIN; TREATMENT OUTCOME; UNITED KINGDOM;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; COLISTIN; COMMUNICABLE DISEASE CONTROL; GEOGRAPHY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MINOCYCLINE; TREATMENT OUTCOME;

EID: 84882712084     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70190-7     Document Type: Review

References (136)

1. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45:1151-1161.
2. Papp-Wallace KM, Bethel CR, Distler AM, Kasuboski C, Taracila M, Bonomo RA Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrob Agents Chemother 2010, 54:890-897.
3. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 2004, 39:55-60.
4. Chiang T, Mariano N, Urban C, et al. Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb Drug Resist 2007, 13:235-239.
5. Pope J, Adams J, Doi Y, Szabo D, Paterson DL KPC type beta-lactamase, rural Pennsylvania. Emerg Infect Dis 2006, 12:1613-1614.
6. Hossain A, Ferraro MJ, Pino RM, et al. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother 2004, 48:4438-4440.
7. Smith ME, Hanson ND, Herrera VL, et al. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 2003, 51:711-714.
8. Healthcare-associated infections. Tracking CRE Centers for Disease Control and Prevention, (accessed Oct 23, 2012). http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html.
9. Vital signs: carbapenem-resistant enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013, 62:165-170. Centers for Disease Control and Prevention (CDC).
10. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009, 53:3365-3370.
11. Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009, 53:818-820.
12. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011, 53:532-540.
13. Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P mirabilis. J Clin Microbiol 2008, 46:3080-3083.
14. Rasheed JK, Biddle JW, Anderson KF, et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K oxytoca carrying a common plasmid. J Clin Microbiol 2008, 46:2066-2069.
15. Bratu S, Landman D, Alam M, Tolentino E, Quale J Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother 2005, 49:776-778.
16. Robledo IE, Aquino EE, Vazquez GJ Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother 2011, 55:2968-2970.
17. Poirel L, Nordmann P, Lagrutta E, Cleary T, Munoz-Price LS Emergence of KPC-producing Pseudomonas aeruginosa in the United States. Antimicrob Agents Chemother 2010, 54:3072.
18. Bennett JW, Herrera ML, Lewis JS, Wickes BW, Jorgensen JH KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob Agents Chemother 2009, 53:292-294.
19. Chitnis AS, Caruthers PS, Rao AK, et al. Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 2012, 33:984-992.
20. Viau RA, Hujer AM, Marshall SH, et al. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio. Clin Infect Dis 2012, 54:1314-1321.
21. Endimiani A, Depasquale JM, Forero S, et al. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009, 64:1102-1110.
22. Prabaker KK, Lin MY, McNally M, et al. Transfer from high acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multi-hospital study. Infect Control Hosp Epidemiol 2012, 33:1193-1199.
23. Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010, 31:341-347.
24. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K pneumoniae. Infect Control Hosp Epidemiol 2009, 30:1180-1185.
25. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29:1099-1106.
26. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012, 4:148ra116.
27. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009, 58:256-260. Centers for Disease Control and Prevention (CDC).
28. Healthcare-associated infections. 2012 CRE toolkit-guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) Centers for Disease Control and Prevention, (accessed Oct 23, 2012). http://www.cdc.gov/hai/organisms/cre/cre-toolkit/.
29. Pillai DR, Melano R, Rawte P, et al. Klebsiella pneumoniae carbapenemase, Canada. Emerg Infect Dis 2009, 15:827-829.
30. Goldfarb D, Harvey SB, Jessamine K, Jessamine P, Toye B, Desjardins M Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission. J Clin Microbiol 2009, 47:1920-1922.
31. Chan WW, Peirano G, Smyth DJ, Pitout JD The characteristics of Klebsiella pneumoniae that produce KPC-2 imported from Greece. Diagn Microbiol Infect Dis 2013, 75:317-319.
32. Mataseje LF, Bryce E, Roscoe D, et al. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother 2012, 67:1359-1367.
33. Mojica MF, Correa A, Vargas DA, et al. Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia. Int J Antimicrob Agents 2012, 40:277-279.
34. Villegas MV, Lolans K, Correa A, et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006, 50:2880-2882.
35. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 2007, 51:1553-1555.
36. Lopez JA, Correa A, Navon-Venezia S, et al. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect 2011, 17:52-56.
37. Cuzon G, Naas T, Villegas MV, Correa A, Quinn JP, Nordmann P Wide dissemination of Pseudomonas aeruginosa producing beta-lactamase blaKPC-2 gene in Colombia. Antimicrob Agents Chemother 2011, 55:5350-5353.
38. Gales AC, Castanheira M, Jones RN, Sader HS Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012, 73:354-360.
39. Pasteran FG, Otaegui L, Guerriero L, et al. Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina. Emerg Infect Dis 2008, 14:1178-1180.
40. Gomez SA, Pasteran FG, Faccone D, et al. Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina. Clin Microbiol Infect 2011, 17:1520-1524.
41. Pasteran F, Faccone D, Gomez S, et al. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J Antimicrob Chemother 2012, 67:1291-1293.
42. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009, 53:333-334.
43. Seki LM, Pereira PS, de Souza MP, et al. Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis 2011, 70:274-277.
44. Chagas TP, Seki LM, da Silva DM, Asensi MD Occurrence of KPC-2-producing Klebsiella pneumoniae strains in hospital wastewater. J Hosp Infect 2011, 77:281.
45. Jacome PR, Alves LR, Cabral AB, Lopes AC, Maciel MA First report of KPC-producing Pseudomonas aeruginosa in Brazil. Antimicrob Agents Chemother 2012, 56:4990.
46. Almeida AC, Vilela MA, Cavalcanti FL, Martins WM, Morais MA, Morais MM First description of KPC-2-producing Pseudomonas putida in Brazil. Antimicrob Agents Chemother 2012, 56:2205-2206.
47. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008, 62(suppl 2):ii55-ii63.
48. Woodford N, Zhang J, Warner M, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008, 62:1261-1264.
49. Carbapenemase-producing Enterobacteriaceae in the UK, (accessed Oct 28, 2012). http://www.hpa.org.uk/HPR/archives/2011/news2411.htm.
50. Livermore DM Fourteen years in resistance. Int J Antimicrob Agents 2012, 39:283-294.
51. Roche C, Cotter M, Connell NO, Crowley B First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Euro Surveill 2009, 14:19163.
52. Morris D, Boyle F, Morris C, et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother 2012, 67:2367-2372.
53. Carbapenemase-producing carbapenem resistant Enterobacteriaceae (CRE) in critical care units in Ireland: a national pilot study Health Protection Surveillance Centre, (accessed Oct 24, 2012). http://www.hpsc.ie/hpsc/A-Z/MicrobiologyAntimicrobialResistance/StrategyforthecontrolofAntimicrobialResistanceinIrelandSARI/CarbapenemResistantEnterobacteriaceaeCRE/NationalpilotstudyofCREinCriticalCareUnitsJune2011/File,12906,en.pdf.
54. Curiao T, Morosini MI, Ruiz-Garbajosa P, et al. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 2010, 65:1608-1614.
55. Gomez-Gil MR, Pano-Pardo JR, Romero-Gomez MP, et al. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother 2010, 65:2695-2697.
56. Poirel L, Barbosa-Vasconcelos A, Simoes RR, Da Costa PM, Liu W, Nordmann P Environmental KPC-producing Escherichia coli isolates in Portugal. Antimicrob Agents Chemother 2012, 56:1662-1663.
57. Naas T, Nordmann P, Vedel G, Poyart C Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005, 49:4423-4424.
58. Dortet L, Radu I, Gautier V, Blot F, Chachaty E, Arlet G Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J Antimicrob Chemother 2008, 61:455-457.
59. Cuzon G, Naas T, Demachy MC, Nordmann P Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008, 52:796-797.
60. Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 2008, 52:3725-3736.
61. Potron A, Poirel L, Verdavaine D, Nordmann P Importation of KPC-2-producing Escherichia coli from India. J Antimicrob Chemother 2012, 67:242-243.
62. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France. Antimicrob Agents Chemother 2011, 55:4933-4934.
63. Rogers BA, Sidjabat HE, Paterson DL Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66:1-14.
64. Cuzon G, Naas T, Demachy MC, Nordmann P Nosocomial outbreak of Klebsiella pneumoniae harbouring bla(KPC-3) in France subsequent to a patient transfer from Italy. Int J Antimicrob Agents 2012, 39:448-449.
65. Naas T, Cuzon G, Babics A, et al. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase. J Antimicrob Chemother 2010, 65:1305-1306.
66. Giani T, D'Andrea MM, Pecile P, et al. Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase. J Clin Microbiol 2009, 47:3793-3794.
67. Fontana C, Favaro M, Sarmati L, et al. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010, 3:40.
68. Richter SN, Frasson I, Franchin E, et al. KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units. Gut Pathog 2012, 4:7.
69. Mazzariol A, Lo CG, Ballarini P, et al. Rapid molecular technique analysis of a KPC-3-producing Klebsiella pneumoniae outbreak in an Italian surgery unit. J Chemother 2012, 24:93-96.
70. Mammina C, Bonura C, Di Bernardo F, et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill 2012, 17. pii:20248.
71. EARS-Net database European Center for Disease Prevention and Control, (accessed Oct 23, 2012). http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/database.aspx.
72. Sisto A, D'Ancona F, Meledandri M, et al. Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012. Euro Surveill 2012, 17. pii:20247.
73. Baraniak A, Izdebski R, Herda M, et al. Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob Agents Chemother 2009, 53:4565-4567.
74. Baraniak A, Grabowska A, Izdebski R, et al. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009. Antimicrob Agents Chemother 2011, 55:5493-5499.
75. Tegmark WK, Haeggman S, Gezelius L, et al. Identification of Klebsiella pneumoniae carbapenemase in Sweden. Euro Surveill 2007, 12:E071220.
76. Maltezou HC, Giakkoupi P, Maragos A, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009, 58:213-219.
77. Pournaras S, Protonotariou E, Voulgari E, et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009, 64:348-352.
78. Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010, 50:364-373.
79. Kontopoulou K, Protonotariou E, Vasilakos K, et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J Hosp Infect 2010, 76:70-73.
80. Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011, 17:1798-1803.
81. Maltezou HC, Kontopidou F, Dedoukou X, et al. National action plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece. J Global Antimicrob Resist (in press).
82. Mavroidi A, Miriagou V, Malli E, et al. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 beta-lactamase. Int J Antimicrob Agents 2012, 39:247-250.
83. Wernli D, Haustein T, Conly J, Carmeli Y, Kickbusch I, Harbarth S A call for action: the application of the international health regulations to the global threat of antimicrobial resistance. PLoS Med 2011, 8:e1001022.
84. Van der Bij AK, Pitout JD The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012, 67:2090-2100.
85. Giakkoupi P, Papagiannitsis CC, Miriagou V, et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J Antimicrob Chemother 2011, 66:1510-1513.
86. Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 2009, 14. pii:19218.
87. Hellenic Center for Infectious Disease Control, Ministry of Health (KEEL) National School of Public Health (NSPH) WHONET Greece, (accessed Oct 23, 2012). http://www.mednet.gr/whonet.
88. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008, 52:1413-1418.
89. Schwaber MJ, Lev B, Israeli A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011, 52:848-855.
90. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52:1028-1033.
91. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009, 30:666-671.
92. Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009, 30:972-976.
93. Canton R, Akova M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
94. Ben-David D, Masarwa S, Navon-Venezia S, et al. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 2011, 32:845-853.
95. Jones CH, Tuckman M, Keeney D, Ruzin A, Bradford PA Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials. Antimicrob Agents Chemother 2009, 53:465-475.
96. Kumarasamy K, Kalyanasundaram A Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India. J Antimicrob Chemother 2012, 67:243-244.
97. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
98. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011, 55:1274-1278.
99. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007, 51:763-765.
100. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011, 66:307-312.
101. Li G, Wei Q, Wang Y, Du X, Zhao Y, Jiang X Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China. Eur J Clin Microbiol Infect Dis 2011, 30:575-580.
102. Zhang X, Lu X, Zong Z Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage. Diagn Microbiol Infect Dis 2012, 73:204-206.
103. Ge C, Wei Z, Jiang Y, Shen P, Yu Y, Li L Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China. J Antimicrob Chemother 2011, 66:1184-1186.
104. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012, 18:432-438.
105. Hrabak J, Studentova V, Walkova R, et al. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2012, 50:2441-2443.
106. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 2012, 50:3877-3880.
107. Pournaras S, Poulou A, Tsakris A Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 2010, 65:1319-1321.
108. Wilkinson KM, Winstanley TG, Lanyon C, Cummings SP, Raza MW, Perry JD Comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 2012, 50:3102-3104.
109. Girlich D, Poirel L, Nordmann P Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems. Diagn Microbiol Infect Dis 2013, 75:214-217.
110. Lee GC, Burgess DS Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob 2012, 11:32.
111. Adams-Haduch JM, Potoski BA, Sidjabat HE, Paterson DL, Doi Y Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2009, 53:2700-2701.
112. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012, 25:682-707.
113. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55:943-950.
114. Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012, 56:2108-2113.
115. Kofteridis DP, Alexopoulou C, Valachis A, et al. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 2010, 51:1238-1244.
116. Livermore DM, Mushtaq S, Warner M, et al. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2011, 55:390-394.
117. Livermore DM, Mushtaq S, Warner M, et al. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 2011, 66:48-53.
118. Li JJ, Sheng ZK, Deng M, et al. Epidemic of Klebsiella pneumoniae ST11 clone coproducing KPC-2 and 16S rRNA methylase RmtB in a Chinese University Hospital. BMC Infect Dis 2012, 12:373.
119. Xiao XY, Hunt DK, Zhou J, et al. Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent. J Med Chem 2012, 55:597-605.
120. Hirsch EB, Ledesma KR, Chang KT, Schwartz MS, Motyl MR, Tam VH In vitro activity of MK-7655, a novel beta-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria. Antimicrob Agents Chemother 2012, 56:3753-3757.
121. Page MG, Dantier C, Desarbre E In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli. Antimicrob Agents Chemother 2010, 54:2291-2302.
122. Mushtaq S, Woodford N, Hope R, Adkin R, Livermore DM Activity of BAL30072 alone or combined with beta-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters. J Antimicrob Chemother 2013, 68:1601-1608.
123. Endimiani A, Hujer KM, Hujer AM, Pulse ME, Weiss WJ, Bonomo RA Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2011, 55:82-85.
124. Munoz-Price LS, Quinn JP Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis 2013, 26:378-387.
125. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009, 30:447-452.
126. Gregory CJ, Llata E, Stine N, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010, 31:476-484.
127. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010, 31:620-626.
128. Munoz-Price LS, De La Cuesta C, Adams S, et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K pneumoniae carbapenemase-producing K pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 2010, 31:1074-1077.
129. Ciobotaro P, Oved M, Nadir E, Bardenstein R, Zimhony O An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011, 39:671-677.
130. Borer A, Eskira S, Nativ R, et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel. Infect Control Hosp Epidemiol 2011, 32:1158-1165.
131. Agodi A, Voulgari E, Barchitta M, et al. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 2011, 49:3986-3989.
132. Poulou A, Voulgari E, Vrioni G, et al. Imported Klebsiella pneumoniae carbapenemase-producing K pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination. J Clin Microbiol 2012, 50:2618-2623.
133. Robustillo RA, Diaz-Agero PC, Sanchez ST, Ruiz-Garbajosa P, Pita Lopez MJ, Monge V Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures. Euro Surveill 2012, 17. pii:20086.
134. Landman D, Babu E, Shah N, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother 2012, 67:1427-1431.
135. Poirel L, Potron A, Nordmann P OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012, 67:1597-1606.
136. Bogdanovich T, Adams-Haduch JM, Tian GB, et al. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 2011, 53:373-376.